Results 161 to 170 of about 1,119,893 (198)

Intravenous Iron Sucrose Changes the Intraperitoneal Homeostasis

Blood Purification, 2009
<i>Background/Aims:</i> Intravenous iron infusion is the accepted way of supplementation of that compound in uremic patients. The aim of the study was to evaluate whether this treatment affects intraperitoneal homeostasis in patients on peritoneal dialysis.
A, Breborowicz, A, Połubinska, M, Kupczyk, M, Wanic-Kossowka, D G, Oreopoulos   +4 more
openaire   +2 more sources

Intravenous iron sucrose: Establishing a safe dose

American Journal of Kidney Diseases, 2001
It is now recognized that the majority of patients on epoetin therapy require intravenous (IV) iron supplementation to maximize the response to treatment. Of the IV iron preparations available, iron sucrose has proved its efficacy and safety; however, there are no guidelines or systematic studies examining the optimum safe dosage regimen for this ...
G, Chandler, J, Harchowal, I C, Macdougall   +2 more
openaire   +2 more sources

Rhabdomyolysis After Intravenous Iron Sucrose Infusion During Pregnancy

Obstetrics & Gynecology, 2023
BACKGROUND: Iron infusions have become increasingly common in the treatment of iron-deficiency anemia during pregnancy. Although iron infusions are generally well tolerated, adverse reactions have been reported. CASE: A pregnant patient was diagnosed with rhabdomyolysis after ...
Christina, Ge, Jessica, Reyes, Ruth Anne, Queenan, Robert B, Gherman   +3 more
openaire   +2 more sources

Bioavailability and stability of intravenous iron sucrose originator versus generic iron sucrose AZAD

Pharmaceutical Development and Technology, 2013
Severe iron deficiency requires intravenous iron supplementation to replenish iron stores. Intravenous iron sucrose has been used for decades for the treatment of anemia. New generic iron sucrose products are now marketed for the use in several countries and there is an ongoing discussion about the safety and efficacy of iron sucrose similars.In this ...
Monika, Praschberger, Carolin, Cornelius, Markus, Schitegg, Hans, Goldenberg, Barbara, Scheiber-Mojdehkar, Brigitte, Sturm   +5 more
openaire   +2 more sources

Peritoneal effects of intravenous iron sucrose administration in rats

Translational Research, 2007
Intravenous iron supplementation is commonly used in uremic patients treated with peritoneal dialysis. Infusion of iron compounds results in various systemic noxious effects, mainly because of its prooxidant and proinflammatory actions. The authors studied how the intravenous infusion of iron sucrose (IS) affects intraperitoneal homeostasis in rats ...
Andrzej, Breborowicz, Alicja, Polubinska, Maciej, Breborowicz, Marek, Simon, Maria, Wanic-Kossowska, Dimitrios G, Oreopoulos   +5 more
openaire   +2 more sources

The Safety of Intravenous Iron Sucrose Use in the Elderly Patient

The Consultant Pharmacist, 2007
This study was undertaken to assess the safety and tolerability of the use of intravenous (IV) iron sucrose in the therapy of iron-deficiency anemia in elderly, hemodialysis dependent (HDD), chronic kidney disease (CKD) patients.This was a multicenter, open-label study in a large consecutive sample of 665 HDD-CKD patients (in 11 locations).
John, Reed, Chaim, Charytan, Jerry, Yee
openaire   +2 more sources

Intravenous Iron Sucrose for Children with Iron Deficiency and/or Gastrointestinal Hemorrhage.

Blood, 2009
Abstract Abstract 2006 Poster Board I-1028 Introduction: For decades parenteral iron has been used in patients with iron deficiency unresponsive to oral iron therapy and in hemodialysis-dependent patients receiving erythropoietin therapy. Iron dextran, used extensively in
Katherine Hall, Shelley E. Crary
openaire   +1 more source

Biodistribution and predictive hepatic gene expression of intravenous iron sucrose

Journal of Pharmacological and Toxicological Methods, 2013
We have examined iron biodistribution and hepatic gene expression in rats following administration of the generic Iron Sucrose Azad (ISA) or the reference iron sucrose drug Venofer®.ISA and Venofer® were administered intravenously to normal, non-anemic, male rats at 15 mg/kg (a supra-therapeutic dose-level).
Peter, Elford, Johanne, Bouchard, Léonore, Jaillet, Nick, Pearson, Alexandra, Rogue, Caroline, Sabadie, Roy, Forster   +6 more
openaire   +2 more sources

Intravenous Iron Sucrose in Chinese Hemodialysis Patients with Renal Anemia

Blood Purification, 2008
<i>Background/Aims:</i> Renal anemia is one of the commonest complications of chronic renal failure. Iron deficiency is the most common factor which affects the efficacy of recombinant human erythropoietin (EPO) therapy. Intravenous (i.v.) iron preparations are commonly used in Western countries, but iron sucrose is seldom used in Chinese ...
Han, Li, Shi-xiang, Wang
openaire   +2 more sources

Intravenous iron sucrose complex in the treatment of iron deficiency anemia during pregnancy

European Journal of Obstetrics & Gynecology and Reproductive Biology, 1996
To evaluate the safety and efficacy of intravenous iron sucrose complex (ISC) as compared with oral ferrous sulfate in the treatment of iron deficiency anemia during pregnancy.prospective, open, controlled study in which pregnant women with iron deficiency anemia were sequentially selected from the antenatal clinic and assigned either to ISC (study ...
A K, al-Momen, A, al-Meshari, L, al-Nuaim, A, Saddique, Z, Abotalib, T, Khashogji, M, Abbas   +6 more
openaire   +2 more sources